On Wednesday, May 10, 2023, the Food and Drug Administration (FDA) announced the publication of a new discussion paper titled “Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products.”The discussion paper aims to facilitate a discussion with…
Source: www.jdsupra.com – Read more
Misconfigurations drive 80% of security exposures
A study of over 40 million exposures shows that 80% of them are caused by misconfigurations, giving insight into the current exposure landscape.